Bonds·FX Policy

[Market In] SAMYANG PACKAGING Receives 90 Billion Won in Orders During Corporate Bond Bookbuilding… Sets Record for “Over-Subscription”

Orders Totaling 90 Billion Won for a 2-Year Bond Issuance Targeting 60 Billion Won ‘+12bp’ Marks a Double-Digit Spread

KIM YEON-SEO
2026-08-28 17:56:02
[Edaily Marketin Reporter KIM YEON-SEO ] SAMYANG PACKAGING (A-) met its fundraising target after receiving orders amounting to 1.5 times the target amount during the bookbuilding process for its public corporate bond offering. However, the financing burden increased somewhat as the company raised the funds at an interest rate higher than the average market rate for similar issues.

(Photo: SAMYANG PACKAGING)


According to the investment banking (IB) industry on the 28th, SAMYANG PACKAGING received a total of 90 billion won in orders during the bookbuilding process for its 2-year corporate bonds, which had a target amount of 60 billion won.

SAMYANG PACKAGING had set its target yield range at –30 basis points (bps; 1 bp = 0.01 percentage points) to +30 bps relative to the rates assessed by individual private bond rating agencies, and successfully met its target at +12 bps.

Based on the results of the bookbuilding, SAMYANG PACKAGING plans to consider increasing the issuance amount to up to 100 billion won. NH INVESTMENT & SECURITIES and KB Securities served as the lead underwriters.

The proceeds will be used to refinance existing corporate bonds. SAMYANG PACKAGING plans to repay 60 billion won in unsecured bonds that mature on the issuance date, the 4th of next month. The additional proceeds from the increased issuance will be used for debt repayment and working capital.

Economy

Corporation

IT·Science

Economy

SamsungElectronics Discusses Future Semiconductor Technologies with Domestic and International Universities… Hosts ‘SPARK 2026’

SamsungElectronics hosted “SPARK 2026,” an integrated industry-academia exchange event, to broaden its industry-academia collaboration with domestic universities and jointly explore future directions …
2026-08-28 17:58:33

Corporation

SANIGEN Co., Ltd. Begins Full-Scale Development of New Drug Using “AI-Powered Endolysin to Combat Superbugs”

SANIGEN Co., Ltd.(188260), a company specializing in genome-based microbial diagnosis and control, has announced its leap toward becoming a global innovative biopharmaceutical company, spearheaded by …
2026-08-28 13:14:02

IT·Science

VUNO, Inc. Decides on 31.4 Billion Won Capital Increase… "Aimed at Alleviating Interest Burden"

VUNO, Inc.(338220)announced on the 28th that it has decided to conduct a rights offering worth 31.4 billion won. VUNO, Inc. plans to issue 6.3 million new common shares at 4,980 won per share (planned…
2026-08-28 17:47:02